Critical Care

official impact factor 4.60

Email this article to a friend

Clinical review: Balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use

Thomas G Slama

Critical Care 2008, 12:233 doi:10.1186/cc6994

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.